Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of NABOTA

Food and Healthcare Press Releases Tuesday July 9, 2019 11:00
BALI, Indonesia and SEOUL, South Korea--9 Jul--PRNewswire/InfoQuest

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia July 5-7, 2019 to introduce the excellence of NABOTA(R) (Prabotulinumtoxin A).

The 13th year of IMCAS (International Master Course on Aging Science) Asia is one of the top international conferences for plastic surgery, dermatology and aesthetic science. This year, around 85 corporate participants and 2,200 physicians had the opportunity to participate in the event.

Daewoong hosted an exhibition booth and a stand-alone symposium to present the excellence of NABOTA and meaning of FDA approval as the first 900 kDa botulinum toxin after Botox. Dr. Hema Sundaram, a US dermatologist who participated in the global clinical trial and one of the faculty members of IMCAS Asia, had the opportunity to speak about a massive global study that involved over 2,100 subjects in the US, EU, and Canada.

Dr. Hema Sundaram said, "Every physician wants to treat their patients with a trustable drug product. Botulinum toxin drug product manufactured by Daewoong Pharmaceutical had successfully proved its excellent efficacy and safety through FDA approval based on the fact that its non-inferiority results to Botox in all aspects of wrinkle improvement and stability in large-scale global clinical trials."

Alongside the exhibition, the NABOTA Aesthetic Forum (NAF in Bali) was held by Daewoong Pharmaceutical to invite more than 30 dermatologists and aesthetic surgeons from 6 different countries. This forum was prepared by Daewoong Pharmaceutical for the 5thstraight year to share the opportunity to explore and update the new techniques and trends in the field.

With regards of first botulinum toxin clinical study in Vietnam, Dr. Pham Xuan Hung said, "In comparison study with NABOTA versus Botox, we have confirmed non-inferiority result to Botox, and it was an opportunity to confirm the excellent efficacy and safety of NABOTA from the Vietnamese as well."

"Throughout IMCAS Asia 2019, we have had a good opportunity to prove the excellence of NABOTA to global physicians. Based on NABOTA's proven excellence in quality and manufacturing process, we expect the significant increase of overseas sales and will continuously promote NABOTA's excellence and strengthen its position as a global brand," said Seongsoo Park, Executive Director of NABOTA Business Department in Daewoong Pharmaceutical.

Photo - https://photos.prnasia.com/prnh/20190709/2518038-1
Caption - Daewoong Pharmaceutical Co., Ltd in IMCAS Asia 2019

Latest Press Release

Herbalife Nutrition Expert Shares Valuable Nutrition Tips to Make Smart Food Choices and Promote Healthy Eating Habits

Herbalife Nutrition (NYSE:HLF), a premier global nutrition company, recently invited Dr.Jonathan Yarom, Herbalife Nutrition Advisory Board Member, to share valuable health and nutrition information to its Independent Members in Thailand. Dr. Yarom has...

New Clinical Trial Proves Allen Carr#s Easyway to Stop Smoking Seminars Are at Least as Effective as the UK#s Gold Standard NHS Stop Smoking Service

The largest and most authoritative research trial of its kind has confirmed that Allen Carr's Easyway (ACE) is now a clinically proven, highly effective drug-free alternative to nicotine patches, gum, and e-cigarettes and the study should pave the way...

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics

Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO specialized in...

Califia Farms Completes Landmark $225 Million Financing with Diverse Group of Global Investors

Funding Provides Califia Farms, a leading plant-based food and beverage company, with long-term capital and global support for continued rapid expansion, and disruption of the $1 trillion+ dairy and ready-to-drink coffee markets Califia Farms(R), a...

Herbalife Nutrition Expert Shares Valuable Nutrition Tips to Make Smart Food Choices and Promote Healthy Eating Habits

Herbalife Nutrition (NYSE:HLF), a premier global nutrition company, recently invited Dr.Jonathan Yarom, Herbalife Nutrition Advisory Board Member, to share valuable health and nutrition information to its Independent Members in Thailand. Dr. Yarom has...

Related Topics